TP53 and hepatocellular carcinoma: RFX5/KDM4A exhibited pro-cancer effects by promoting the G0/G1 to S phase transition of the cell cycle in HCC and was also revealed to act on p53 and downstream genes to inhibit cancer cell apoptosis [45].